Galectin antagonist use in mild cases of SARS-CoV-2; pilot feasibility randomised, open label, controlled trial
A Sigamani, S Shetty, Madhavi, M Ruthra, Sudhishma… - medRxiv, 2020 - medrxiv.org
Importance Novel SARS-CoV-2 virus has infected nearly half a billion people across the
world and is highly contagious. There is a need for a novel mechanism to block viral entry and …
world and is highly contagious. There is a need for a novel mechanism to block viral entry and …
Galectin antagonist use in mild cases of SARS-CoV-2 cases; pilot feasibility randomised, open label, controlled trial
A SIGAMANI, M KADAMBI, M RUTHRA… - 2020 - pesquisa.bvsalud.org
ImportanceNovel SARS-CoV-2 virus has infected nearly half a billion people across the world
and is highly contagious. There is a need for a novel mechanism to block viral entry and …
and is highly contagious. There is a need for a novel mechanism to block viral entry and …
